CME Group’s annual profits rose 16% in 2008 and even fourth quarter earnings kept pace with those of last year, despite a decline in trading of its key asset class, interest rate derivatives, which has now lasted for nine months. But the outlook for 2009 is bleak, with sharp falls in trading volumes for all products in January.
Net income in 2008 was 16% up at $1.08bn and diluted earnings a share rose the same amount to $16.17. Revenues rose 11% from $2.74bn to $3.05bn, on a pro forma non-GAAP basis.
Using that analysis, revenues for the fourth quarter of the year were up 31% at...